Vimarsana
Biggest News Aggregation in the World

Tom Plitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tom Plitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tom Plitz Today - Breaking & Trending Today

Relief Reports Full-Year 2021 Results and Provides Corporate Update - Vimarsana News

Relief Reports Full-Year 2021 Results and Provides Corporate Update

Relief Reports Full-Year 2021 Results and Provides Corporate Update

EQS-Adhoc: Relief Therapeutics Holding SA: Relief Reports Full-Year 2021 Results and Provides Corporate Update - Vimarsana News

EQS-Adhoc: Relief Therapeutics Holding SA: Relief Reports Full-Year 2021 Results and Provides Corporate Update

Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant

Relief Reports Full-Year 2021 Results and Provides Corporate Update - Vimarsana News

Relief Reports Full-Year 2021 Results and Provides Corporate Update

Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-202...

Merck Buys Chord Therapeutics - Vimarsana News

Merck Buys Chord Therapeutics

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority - Press Release - Vimarsana News

Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority - Press Release

GENEVA, SWITZERLAND / ACCESSWIRE / December 18, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday's Extraordinary General Meeting (" EGM") were approved with a large majority (more than 90 percent) of the represented votes. As a result of the exceptional circumstances due to the coronavirus pandemic, the EGM was held without the physical presence of shareholders, repr...